“The main issue is that at-home devices tend to be underpowered,” said Dr. Tito Vasquez, assistant professor of plastic ...

The FDA granted breakthrough therapy status to first-line petosemtamab plus pembrolizumab for PD-L1–positive recurrent or ...

The Ganga River at Prayagraj faces significant faecal coliform contamination, especially during the Maha Kumbh Mela, posing ...

The unexpected nature of hidradenitis suppurativa means that it may impact people in different ways and varying degrees of severity.

Nikki A. Levin, MD, PhD, is an Assistant Professor of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA. Note: The author reported no actual or potential ...

Bristol Myers Squibb today announced new five-year results from the POETYK PSO long-term extension (LTE) trial of Sotyktu (deucravacitinib) treatment in adult patients with moderate-to-severe plaque ...